Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

PORTEC Study Grp

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1273-1285
Number of pages13
JournalLancet oncology
Volume20
Issue number9
DOIs
Publication statusPublished - Sep 2019

Keywords

  • CARCINOMA PATIENTS
  • OPEN-LABEL
  • III TRIAL
  • CHEMOTHERAPY
  • RADIATION
  • MULTICENTER
  • IRRADIATION
  • THERAPY

Cite this